May 27, 2026 Personalised thrombo-embolic risk prediction after endometrial cancer surgery: an explainable AI approach using SHAP
May 26, 2026 Lundbeck receives marketing authorization for Vyepti® (eptinezumab) in South Korea for the preventive treatment of migraine
February 14, 2026 FDA Rejects Disc Medicine’s Porphyria Drug Bitopertin – First Under Makary’s Fast-Track Program
